The U.Ok. authorities had, in July, mentioned all adults over 50 could be supplied a COVID-19 vaccine booster dose (no vaccine was specified) within the autumn.
The U.Ok. authorities had, in July, mentioned all adults over 50 could be supplied a COVID-19 vaccine booster dose (no vaccine was specified) within the autumn.
British well being authorities, on August 15, 2022, authorised using Moderna’s omicron variant-specific COVID-19 vaccine booster for adults, the primary nation to take action. The Medicines and Healthcare merchandise Regulatory Agency (MHRA) granted conditional approval to Moderna’s bivalent vaccine, Spikevax, which mixes mRNA sequences that code for the SARS-CoV-2 spike protein from each the unique and the Omicron BA.1 variant.
The U.Ok. authorities had, in July, mentioned all adults over 50 could be supplied a COVID-19 vaccine booster dose (no vaccine was specified) within the autumn.
The vaccine offered a “strong immune response” towards the unique pressure of the virus in addition to the BA.1 pressure, MHRA Chief Executive June Raine mentioned in a press release.
“Like all medicines, the vaccine can cause side effects, although not everybody gets them,” mentioned a affected person data sheet on Spikevax, revealed by the UK authorities. Included within the potential uncomfortable side effects are an elevated threat of myocarditis/pericarditis (irritation of the warmth muscle/ pericardium , the liner across the coronary heart). A number of circumstances of capillary leak syndrome (CLS), i.e., the leakage of fluid from small blood vessels, have additionally been reported.
“We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines and this will include the vaccine approved today,” Ms Raine mentioned.
Source: www.thehindu.com